LFCR
LIFECORE BIOMEDICAL, INC. \DE\
Company overview
- Market capitalization
- $246.80M
- Employees
- 382
- Latest publication
- 2026-09-29
About LIFECORE BIOMEDICAL, INC. \DE\
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q3 20262026-02-28 · USD | Q1 20262025-08-31 · USD | Q4 20252025-05-31 · USD | Q3 20252025-02-28 · USD | Q2 20252024-11-30 · USD | Q1 20252024-08-31 · USD | Q4 20242024-05-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 34,167,000USD | 23,193,000USD | 31,109,000USD | 36,444,000USD | 35,154,000USD | 32,564,000USD | 24,705,000USD | 37,886,000USD |
| Cost Of Revenue | 22,092,000USD | 18,731,000USD | 23,318,000USD | 22,462,000USD | 25,309,000USD | 21,480,000USD | 19,318,000USD | 20,614,000USD |
| Gross Profit | 12,075,000USD | 4,462,000USD | 7,791,000USD | 13,982,000USD | 9,845,000USD | 11,084,000USD | 5,387,000USD | 17,272,000USD |
| Research Development | 1,537,000USD | 1,217,000USD | 1,963,000USD | 2,103,000USD | 2,045,000USD | 1,924,000USD | 2,186,000USD | 2,161,000USD |
| Selling General Administrative | 7,971,000USD | 7,917,000USD | 8,895,000USD | 8,980,000USD | 10,093,000USD | 11,119,000USD | 14,302,000USD | 12,224,000USD |
| Total Operating Expenses | 9,508,000USD | 9,134,000USD | 10,858,000USD | 8,655,000USD | 18,874,000USD | 13,043,000USD | 16,971,000USD | 15,123,000USD |
| Operating Income | 2,567,000USD | -4,672,000USD | -3,067,000USD | 5,327,000USD | -9,029,000USD | -1,959,000USD | -11,584,000USD | 2,149,000USD |
| Total Other Income Expense Net | -8,700,000USD | -10,265,000USD | -6,591,000USD | -6,441,000USD | -5,748,000USD | -4,569,000USD | -4,671,000USD | -9,292,000USD |
| Interest Income | 144,000USD | 128,000USD | 58,000USD | — | 108,000USD | — | 15,000USD | — |
| Income Before Tax | -6,133,000USD | -14,937,000USD | -9,658,000USD | -1,114,000USD | -14,777,000USD | -6,528,000USD | -16,255,000USD | -7,143,000USD |
| Income Tax Expense | 23,000USD | 43,000USD | 333,000USD | 33,000USD | -8,000USD | 43,000USD | -25,000USD | -57,000USD |
| Net Income | -6,156,000USD | -14,980,000USD | -9,991,000USD | -1,147,000USD | -14,769,000USD | -6,571,000USD | -16,230,000USD | -7,083,000USD |
| Net Income Applicable To Common Shares | -7,127,000USD | — | — | — | — | — | — | — |
| Interest Expense | — | 7,348,000USD | 551,000USD | 5,521,000USD | 5,481,000USD | 5,465,000USD | 5,368,000USD | 5,790,000USD |
| Net Interest Income | — | -7,220,000USD | -6,326,000USD | -5,521,000USD | -5,481,000USD | -5,465,000USD | -5,368,000USD | -5,790,000USD |
| Tax Provision | — | 43,000USD | 333,000USD | 33,000USD | -8,000USD | 43,000USD | -25,000USD | -57,000USD |
| Net Income From Continuing Ops | — | -14,980,000USD | -9,991,000USD | -1,147,000USD | -14,769,000USD | -6,571,000USD | -16,230,000USD | -7,086,000USD |
| Ebit | — | -4,672,000USD | -9,107,000USD | 4,407,000USD | -9,296,000USD | -1,063,000USD | -10,887,000USD | -1,353,000USD |
| Ebitda | — | -2,362,000USD | -7,126,000USD | 6,321,000USD | -7,220,000USD | 981,000USD | -8,894,000USD | 899,000USD |
| Depreciation And Amortization | — | 2,310,000USD | 1,981,000USD | 1,914,000USD | 2,076,000USD | 2,044,000USD | 1,993,000USD | 2,252,000USD |
| Reconciled Depreciation | — | 2,310,000USD | 1,981,000USD | 1,914,000USD | 2,076,000USD | 2,044,000USD | 1,993,000USD | 2,252,000USD |
| Unclassified Operating Expenses | — | — | — | -2,428,000USD | 6,736,000USD | — | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-05-31 · USD | FY 20242024-05-31 · USD | FY 20232023-05-31 · USD | FY 20222022-05-31 · USD | FY 20212021-05-31 · USD | FY 20202020-05-31 · USD | FY 20192019-05-31 · USD | FY 20182018-05-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 128,867,000USD | 128,261,000USD | 111,270,000USD | 185,786,000USD | 100,874,000USD | 160,066,000USD | 557,559,000USD | 524,227,000USD |
| Cost Of Revenue | 88,569,000USD | 86,411,000USD | 72,204,000USD | 135,416,000USD | 61,937,000USD | 120,679,000USD | 476,556,000USD | 445,889,000USD |
| Gross Profit | 40,298,000USD | 41,850,000USD | 39,066,000USD | 50,370,000USD | 38,937,000USD | 39,387,000USD | 81,003,000USD | 78,338,000USD |
| Research Development | 8,258,000USD | 8,575,000USD | 7,839,000USD | 7,841,000USD | 6,684,000USD | 7,582,000USD | 11,466,000USD | 12,800,000USD |
| Selling General Administrative | 44,046,000USD | 43,012,900USD | 42,431,000USD | 46,127,000USD | 65,264,000USD | 72,088,000USD | 62,762,000USD | 50,551,000USD |
| Unclassified Operating Expenses | 5,239,000USD | — | — | — | -24,188,000USD | -14,407,000USD | — | — |
| Total Operating Expenses | 57,543,000USD | 50,694,000USD | 50,857,000USD | 53,968,000USD | 47,760,000USD | 65,263,000USD | 75,528,000USD | 64,751,000USD |
| Operating Income | -17,245,000USD | -8,844,000USD | -11,791,000USD | -3,598,000USD | -8,823,000USD | -25,876,000USD | -8,010,000USD | 11,848,000USD |
| Interest Income | 333,000USD | 58,000USD | 68,000USD | 81,000USD | 48,000USD | 103,000USD | 145,000USD | — |
| Interest Expense | 21,835,000USD | 18,090,000USD | 15,551,000USD | 17,357,000USD | 8,933,000USD | 4,646,000USD | 5,230,000USD | 1,950,000USD |
| Net Interest Income | -21,835,000USD | -18,090,000USD | -18,116,000USD | -17,276,000USD | -15,296,000USD | -9,500,000USD | -5,085,000USD | — |
| Income Before Tax | -38,674,000USD | 9,514,000USD | -20,687,000USD | -52,115,000USD | -29,787,000USD | -30,645,000USD | 3,640,000USD | 16,398,000USD |
| Income Tax Expense | 43,000USD | 183,000USD | -5,211,000USD | -5,839,000USD | -6,350,000USD | -8,774,000USD | 1,518,000USD | -9,363,000USD |
| Tax Provision | 43,000USD | 183,000USD | 301,000USD | -5,839,000USD | -7,801,000USD | -13,116,000USD | 1,518,000USD | — |
| Net Income | -38,717,000USD | 12,013,000USD | -116,715,000USD | -97,431,000USD | -32,294,000USD | -38,191,000USD | 2,122,000USD | 24,829,000USD |
| Net Income From Continuing Ops | -38,717,000USD | 9,331,000USD | -69,003,000USD | -46,276,000USD | -32,665,000USD | -38,191,000USD | 2,122,000USD | — |
| Ebit | -16,839,000USD | 27,604,000USD | -5,217,000USD | -85,913,000USD | -20,854,000USD | -25,999,000USD | 8,870,000USD | 13,018,000USD |
| Ebitda | -8,812,000USD | 35,604,000USD | 12,844,000USD | -68,029,000USD | -987,000USD | -7,161,000USD | 23,470,000USD | 24,987,000USD |
| Depreciation And Amortization | 8,027,000USD | 8,000,000USD | 18,061,000USD | 17,884,000USD | 19,867,000USD | 18,838,000USD | 14,600,000USD | 11,969,000USD |
| Reconciled Depreciation | 8,027,000USD | 8,859,000USD | 13,508,000USD | 17,884,000USD | 19,867,000USD | 18,838,000USD | 15,230,000USD | — |
| Total Other Income Expense Net | -21,429,000USD | 18,358,000USD | -8,896,000USD | -48,517,000USD | -20,964,000USD | -4,769,000USD | -1,835,000USD | 2,811,000USD |
| Selling And Marketing Expenses | — | 5,100USD | 200,000USD | — | — | — | 1,300,000USD | 1,400,000USD |
| Discontinued Operations | — | — | -33,187,000USD | -51,155,000USD | -23,096,000USD | -16,320,000USD | -1,711,000USD | — |
| Net Income Applicable To Common Shares | — | — | -102,190,000USD | -97,431,000USD | -32,665,000USD | -38,191,000USD | 411,000USD | — |
| Minority Interest | — | — | — | — | — | 0USD | 0USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q3 20262026-02-28 · USD | Q1 20262025-08-31 · USD | Q4 20252025-05-31 · USD | Q3 20252025-02-28 · USD | Q2 20252024-11-30 · USD | Q1 20252024-08-31 · USD | Q4 20242024-05-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 229,500,000USD | 225,499,000USD | 235,204,000USD | 239,342,000USD | 237,693,000USD | 255,386,000USD | 246,824,000USD | 253,960,000USD |
| Cash And Equivalents | 17,241,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 83,691,000USD | 77,639,000USD | 83,928,000USD | 85,677,000USD | 84,211,000USD | 81,858,000USD | 74,183,000USD | 81,033,000USD |
| Other Current Assets | 2,952,000USD | 1,803,000USD | 2,138,000USD | 1,454,000USD | 24,834,000USD | 13,012,000USD | 1,876,000USD | 1,439,000USD |
| Other Non Current Assets | 8,214,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 213,407,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 21,641,000USD | 20,497,000USD | 29,958,000USD | 30,178,000USD | 31,116,000USD | 35,290,000USD | 40,523,000USD | 38,872,000USD |
| Other Current Liabilities | 14,107,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 6,746,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | -34,094,000USD | 20,778,000USD | 36,786,000USD | 1,336,000USD | 2,229,000USD | 15,449,000USD | -3,938,000USD | 11,315,000USD |
| Total Equity Including Noncontrolling Interest | 16,093,000USD | — | — | — | — | — | — | — |
| Inventory | 25,475,000USD | 28,155,000USD | 33,801,000USD | 32,291,000USD | 34,596,000USD | 39,214,000USD | 41,642,000USD | 39,979,000USD |
| Property Plant Equipment Net | 123,714,000USD | 125,513,000USD | 123,631,000USD | 129,006,000USD | 130,456,000USD | 152,880,000USD | 151,129,000USD | 149,165,000USD |
| Goodwill | 13,881,000USD | — | — | — | — | — | — | — |
| Accounts Payable | 7,534,000USD | 6,639,000USD | 10,115,000USD | 8,220,000USD | 7,405,000USD | 14,967,000USD | 18,010,000USD | 16,334,000USD |
| Common Stock | 38,000USD | 37,000USD | 37,000USD | 37,000USD | 37,000USD | 37,000USD | 31,000USD | 31,000USD |
| Retained Earnings | -244,337,000USD | -238,181,000USD | -218,095,000USD | -205,240,000USD | -204,093,000USD | -191,456,000USD | -182,753,000USD | -166,523,000USD |
| Intangible Assets | — | 4,200,000USD | 4,200,000USD | 4,200,000USD | 4,200,000USD | 4,200,000USD | 4,200,000USD | 4,200,000USD |
| Total Liab | — | 204,721,000USD | 198,418,000USD | 238,006,000USD | 235,464,000USD | 239,937,000USD | 250,762,000USD | 242,645,000USD |
| Other Current Liab | — | 6,657,000USD | 18,528,000USD | 14,719,000USD | 16,250,000USD | 14,497,000USD | 16,945,000USD | 15,519,000USD |
| Capital Stock | — | 37,000USD | 37,000USD | 37,000USD | 37,000USD | 37,000USD | 31,000USD | 30,000USD |
| Good Will | — | 13,881,000USD | 13,881,000USD | 13,881,000USD | 13,881,000USD | 13,881,000USD | 13,881,000USD | 13,881,000USD |
| Cash | — | 20,795,000USD | 18,856,000USD | 8,265,000USD | 5,417,000USD | 9,455,000USD | 5,520,000USD | 8,462,000USD |
| Cash And Short Term Investments | — | 20,795,000USD | 18,856,000USD | 8,265,000USD | 5,417,000USD | 9,455,000USD | 5,520,000USD | 8,462,000USD |
| Current Deferred Revenue | — | 5,864,000USD | — | 3,415,000USD | 2,565,000USD | 937,000USD | 654,000USD | 2,113,000USD |
| Net Debt | — | 129,346,000USD | 118,677,000USD | 122,558,000USD | 124,924,000USD | 121,885,000USD | 131,344,000USD | 125,113,000USD |
| Short Term Debt | — | 1,337,000USD | 1,315,000USD | 3,824,000USD | 4,896,000USD | 4,889,000USD | 4,914,000USD | 4,906,000USD |
| Short Long Term Debt | — | 773,000USD | 947,000USD | 3,437,000USD | 930,000USD | 773,000USD | 773,000USD | 773,000USD |
| Short Long Term Debt Total | — | 150,141,000USD | 137,533,000USD | 130,823,000USD | 130,341,000USD | 131,340,000USD | 136,864,000USD | 133,575,000USD |
| Long Term Debt | — | 142,137,000USD | 135,004,000USD | 126,999,000USD | 124,009,000USD | 119,028,000USD | 127,150,000USD | 120,510,000USD |
| Net Receivables | — | 26,886,000USD | 29,133,000USD | 43,667,000USD | 19,364,000USD | 20,177,000USD | 25,145,000USD | 31,153,000USD |
| Property Plant Equipment Gross | — | 186,131,000USD | 188,197,000USD | 186,418,000USD | 185,954,000USD | 207,251,000USD | 203,456,000USD | 201,374,000USD |
| Common Stock Shares Outstanding | — | 37,477,386shares | 37,402,912shares | 37,026,234shares | 37,020,570shares | 34,360,657shares | 30,855,742shares | 30,563,000shares |
| Non Current Assets Total | — | 147,860,000USD | 151,276,000USD | 153,665,000USD | 153,482,000USD | 173,528,000USD | 172,641,000USD | 172,927,000USD |
| Non Current Liabilities Total | — | 184,224,000USD | 168,460,000USD | 207,828,000USD | 159,151,000USD | 160,336,000USD | 210,239,000USD | 203,773,000USD |
| Non Current Liabilities Other | — | 6,726,000USD | 7,965,000USD | 9,741,000USD | 9,806,000USD | 5,153,000USD | 5,114,000USD | 5,086,000USD |
| Non Currrent Assets Other | — | 8,466,000USD | 9,564,000USD | 6,578,000USD | 3,250,000USD | 2,567,000USD | 3,431,000USD | 5,681,000USD |
| Net Working Capital | — | 57,142,000USD | 53,970,000USD | 55,499,000USD | 53,095,000USD | 46,568,000USD | 33,660,000USD | 42,161,000USD |
| Unclassified Non Current Assets | — | -4,200,000USD | — | — | 1,695,000USD | — | — | — |
| Unclassified Non Current Liabilities | — | 35,361,000USD | 25,491,000USD | 71,088,000USD | 25,336,000USD | 36,155,000USD | 77,975,000USD | 78,177,000USD |
| Unclassified Equity | — | 258,885,000USD | 254,807,000USD | 206,502,000USD | 206,248,000USD | 206,831,000USD | 222,194,000USD | 220,364,000USD |
| Unclassified Current Liabilities | — | — | — | -3,437,000USD | — | — | — | — |
| Accumulated Other Comprehensive Income | — | — | — | — | — | — | -43,441,000USD | -42,587,000USD |
| Other Assets | — | — | — | — | — | — | — | 1USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20262026-05-31 · USD | FY 20252025-05-31 · USD | FY 20242024-05-31 · USD | FY 20232023-05-31 · USD | FY 20222022-05-31 · USD | FY 20212021-05-31 · USD | FY 20202020-05-31 · USD | FY 20192019-05-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 232,177,000USD | 239,342,000USD | 253,960,000USD | 274,703,000USD | 295,160,000USD | 502,924,000USD | 541,313,000USD | 519,091,000USD |
| Other Current Assets | 1,921,000USD | 1,454,000USD | 1,439,000USD | 41,363,000USD | 7,052,000USD | 42,656,000USD | 14,230,000USD | 8,264,000USD |
| Total Liab | 246,379,000USD | 238,006,000USD | 242,645,000USD | 186,880,000USD | 187,215,000USD | 300,140,000USD | 310,269,000USD | 248,947,000USD |
| Total Stockholder Equity | -14,202,000USD | 1,336,000USD | 11,315,000USD | 87,823,000USD | 107,945,000USD | 202,784,000USD | 231,044,000USD | 270,144,000USD |
| Other Current Liab | 7,748,000USD | 14,719,000USD | 15,519,000USD | 20,164,000USD | 16,885,000USD | 54,353,000USD | 19,012,000USD | 20,726,000USD |
| Common Stock | 37,000USD | 37,000USD | 31,000USD | 30,000USD | 30,000USD | 29,000USD | 29,000USD | 29,000USD |
| Capital Stock | 37,000USD | 37,000USD | 30,000USD | 30,000USD | 30,000USD | 29,000USD | 29,000USD | 29,000USD |
| Retained Earnings | -223,201,000USD | -205,240,000USD | -166,523,000USD | -78,973,000USD | -58,851,000USD | 38,580,000USD | 71,245,000USD | 109,710,000USD |
| Good Will | 13,881,000USD | 13,881,000USD | 13,881,000USD | 13,881,000USD | 13,881,000USD | 33,916,000USD | 69,386,000USD | 76,742,000USD |
| Cash | 17,469,000USD | 8,265,000USD | 8,462,000USD | 991,000USD | 1,643,000USD | 1,159,000USD | 360,000USD | 1,080,000USD |
| Cash And Short Term Investments | 17,469,000USD | 8,265,000USD | 8,462,000USD | 991,000USD | 1,643,000USD | 1,159,000USD | 360,000USD | 1,080,000USD |
| Total Current Assets | 82,292,000USD | 85,677,000USD | 81,033,000USD | 116,668,000USD | 123,712,000USD | 148,321,000USD | 157,107,000USD | 133,041,000USD |
| Total Current Liabilities | 23,573,000USD | 30,178,000USD | 38,872,000USD | 176,581,000USD | 79,231,000USD | 101,888,000USD | 164,388,000USD | 137,091,000USD |
| Current Deferred Revenue | 8,660,000USD | 3,415,000USD | 2,113,000USD | 919,000USD | 919,000USD | 637,000USD | 352,000USD | 499,000USD |
| Net Debt | 125,139,000USD | 122,558,000USD | 125,113,000USD | 246,792,000USD | 151,544,000USD | 214,702,000USD | 220,758,000USD | 151,436,000USD |
| Short Term Debt | 1,326,000USD | 3,824,000USD | 4,906,000USD | 142,546,000USD | 45,625,000USD | 30,600,000USD | 93,377,000USD | 61,893,000USD |
| Short Long Term Debt | 773,000USD | 3,437,000USD | 773,000USD | 488,000USD | 40,599,000USD | 29,000,000USD | 88,954,000USD | 61,791,000USD |
| Short Long Term Debt Total | 142,608,000USD | 130,823,000USD | 133,575,000USD | 247,783,000USD | 153,187,000USD | 215,861,000USD | 221,118,000USD | 152,516,000USD |
| Long Term Debt | 135,588,000USD | 126,999,000USD | 120,510,000USD | 101,273,000USD | 97,579,000USD | 164,902,000USD | 101,363,000USD | 87,193,000USD |
| Net Receivables | 33,817,000USD | 43,667,000USD | 31,153,000USD | 38,314,000USD | 48,172,000USD | 41,430,000USD | 76,206,000USD | 69,565,000USD |
| Inventory | 29,085,000USD | 32,291,000USD | 39,979,000USD | 36,000,000USD | 66,845,000USD | 63,076,000USD | 66,311,000USD | 54,132,000USD |
| Accounts Payable | 5,839,000USD | 8,220,000USD | 16,334,000USD | 12,952,000USD | 15,802,000USD | 16,298,000USD | 51,647,000USD | 53,973,000USD |
| Property Plant Equipment Net | 127,304,000USD | 129,006,000USD | 149,165,000USD | 124,223,000USD | 139,015,000USD | 137,384,000USD | 217,659,000USD | 200,027,000USD |
| Property Plant Equipment Gross | 186,464,000USD | 186,418,000USD | 201,374,000USD | 134,593,000USD | 139,015,000USD | 200,386,000USD | 217,659,000USD | — |
| Common Stock Shares Outstanding | 37,477,386shares | 34,818,906shares | 36,658,000shares | 29,466,000shares | 29,513,000shares | 29,294,000shares | 29,162,000shares | 28,607,000shares |
| Non Current Assets Total | 149,885,000USD | 153,665,000USD | 172,927,000USD | 158,035,000USD | 171,448,000USD | 354,603,000USD | 384,206,000USD | 386,050,000USD |
| Non Current Liabilities Total | 222,806,000USD | 207,828,000USD | 203,773,000USD | 10,299,000USD | 107,984,000USD | 198,252,000USD | 145,881,000USD | 111,856,000USD |
| Non Current Liabilities Other | 6,698,000USD | 9,741,000USD | 5,086,000USD | 3,114,000USD | 190,000USD | 3,599,000USD | 4,552,000USD | 1,738,000USD |
| Non Currrent Assets Other | 8,700,000USD | 6,578,000USD | 5,681,000USD | 15,731,000USD | 3,002,000USD | 112,571,000USD | -25,305,000USD | -9,744,000USD |
| Net Working Capital | 58,719,000USD | 55,499,000USD | 42,161,000USD | 60,483,000USD | 44,481,000USD | 46,433,000USD | -7,281,000USD | -4,050,000USD |
| Unclassified Non Current Liabilities | 80,520,000USD | 71,088,000USD | 78,177,000USD | -97,575,000USD | 9,793,000USD | 18,496,000USD | 25,404,000USD | 2,276,000USD |
| Unclassified Equity | 208,925,000USD | 206,502,000USD | 220,364,000USD | 167,322,000USD | 167,322,000USD | 165,504,000USD | 162,549,000USD | 160,312,000USD |
| Intangible Assets | — | 4,200,000USD | 4,200,000USD | 4,200,000USD | 15,550,000USD | 25,632,000USD | 38,105,000USD | 45,247,000USD |
| Unclassified Current Liabilities | — | -3,437,000USD | — | — | -40,599,000USD | -29,000,000USD | -88,954,000USD | -61,791,000USD |
| Other Assets | — | — | 19,742,000USD | 3,215,000USD | 3,002,000USD | 157,671,000USD | 2,156,000USD | 2,290,000USD |
| Accumulated Other Comprehensive Income | — | — | -42,587,000USD | -586,000USD | -586,000USD | -1,358,000USD | -2,808,000USD | 64,000USD |
| Unclassified Non Current Assets | — | — | -19,742,000USD | -3,215,000USD | -3,002,000USD | -157,671,000USD | — | — |
| Other Liab | — | — | — | 3,487,000USD | 422,000USD | 11,255,000USD | 14,562,000USD | 20,649,000USD |
| Net Tangible Assets | — | — | — | -19,923,000USD | 78,514,000USD | 143,236,000USD | 123,553,000USD | 148,155,000USD |
| Long Term Investments | — | — | — | — | — | 45,100,000USD | 56,900,000USD | 61,100,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q3 20262026-02-28 · USD | Q2 20262025-11-30 · USD | Q1 20262025-08-31 · USD | Q4 20252025-05-31 · USD | Q3 20252025-02-28 · USD | Q2 20252024-11-30 · USD | Q1 20252024-08-31 · USD | Q4 20242024-05-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -14,980,000USD | -6,046,000USD | -9,991,000USD | -1,147,000USD | -14,769,000USD | -6,571,000USD | -16,230,000USD | -7,083,000USD |
| Depreciation | 2,310,000USD | — | 1,981,000USD | 1,913,000USD | 2,076,000USD | 2,044,000USD | 1,993,000USD | 2,252,000USD |
| Stock Based Compensation | 1,698,000USD | — | 2,392,000USD | 1,815,000USD | 2,552,000USD | 3,372,000USD | 2,419,000USD | 1,598,000USD |
| Other Non Cash Items | 11,891,000USD | — | 6,742,000USD | 3,759,000USD | 16,342,000USD | 3,632,000USD | 3,808,000USD | 7,385,000USD |
| Change To Account Receivables | 6,565,000USD | — | 65,000USD | 421,000USD | -3,683,000USD | -5,019,000USD | 6,019,000USD | 106,000USD |
| Change To Inventory | 930,000USD | — | 1,968,000USD | 2,304,000USD | 4,619,000USD | 2,428,000USD | -1,663,000USD | -309,000USD |
| Change In Working Capital | 5,479,000USD | — | 638,000USD | -1,026,000USD | -2,440,000USD | -8,696,000USD | 7,467,000USD | 4,552,000USD |
| Total Cash From Operating Activities | 4,700,000USD | — | 1,762,000USD | 5,347,000USD | 1,200,000USD | -6,110,000USD | -643,000USD | 8,640,000USD |
| Capital Expenditures | -1,118,000USD | 0USD | -1,737,000USD | -2,097,000USD | -5,456,000USD | -2,470,000USD | -3,392,000USD | -2,637,000USD |
| Free Cash Flow | 3,582,000USD | — | 25,000USD | 3,250,000USD | -4,256,000USD | -8,580,000USD | -4,035,000USD | 6,003,000USD |
| Total Cashflows From Investing Activities | -1,118,000USD | — | -1,737,000USD | -2,097,000USD | 1,544,000USD | -2,470,000USD | -3,392,000USD | -2,637,000USD |
| Net Borrowings | 0USD | — | -232,000USD | -231,000USD | -6,231,000USD | -10,940,000USD | 1,681,000USD | — |
| Total Cash From Financing Activities | -256,000USD | — | -1,388,000USD | -402,000USD | -6,782,000USD | 12,515,000USD | 1,093,000USD | -614,000USD |
| Change In Cash | 3,326,000USD | — | -1,363,000USD | 2,848,000USD | -4,038,000USD | 3,935,000USD | -2,942,000USD | 5,389,000USD |
| Begin Period Cash Flow | 17,469,000USD | 18,856,000USD | 20,219,000USD | 5,417,000USD | 9,455,000USD | 5,520,000USD | 8,462,000USD | 3,073,000USD |
| End Period Cash Flow | 20,795,000USD | 18,856,000USD | 18,856,000USD | 8,265,000USD | 5,417,000USD | 9,455,000USD | 5,520,000USD | 8,462,000USD |
| Other Cashflows From Financing Activities | -256,000USD | — | -1,156,000USD | 2,237,000USD | -133,000USD | -385,000USD | -589,000USD | -739,000USD |
| Unclassified Operating Cash Flow | -1,698,000USD | — | — | — | -2,561,000USD | — | — | — |
| Investments | — | — | -1,737,000USD | -2,097,000USD | 1,544,000USD | -2,470,000USD | -3,392,000USD | -2,637,000USD |
| Issuance Of Capital Stock | — | — | 0USD | -8,000USD | 17,000USD | 23,840,000USD | 1,000USD | 0USD |
| Unclassified Investing Cash Flow | — | — | 1,737,000USD | 2,097,000USD | -1,544,000USD | 2,470,000USD | 3,392,000USD | 2,637,000USD |
| Unclassified Financing Cash Flow | — | — | — | -2,400,000USD | -1,007,000USD | — | 1,396,000USD | — |
| Sale Purchase Of Stock | — | — | — | — | 589,000USD | — | -589,000USD | -42,000USD |
| Other Cashflows From Investing Activities | — | — | — | — | 7,000,000USD | — | — | — |
| Dividends Paid | — | — | — | — | — | — | -806,000USD | -748,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-05-31 · USD | FY 20242024-05-31 · USD | FY 20232023-05-31 · USD | FY 20222022-05-31 · USD | FY 20212021-05-31 · USD | FY 20202020-05-31 · USD | FY 20192019-05-31 · USD | FY 20182018-05-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -38,717,000USD | 12,013,000USD | -116,715,000USD | -97,431,000USD | -32,294,000USD | -15,149,000USD | 411,000USD | 24,923,000USD |
| Depreciation | 8,027,000USD | 7,954,000USD | 18,061,000USD | 17,884,000USD | 19,867,000USD | 18,838,000USD | 15,230,000USD | 12,412,000USD |
| Stock Based Compensation | 10,158,000USD | 6,201,000USD | 2,608,000USD | 2,608,000USD | 3,360,000USD | 2,375USD | 3,560,000USD | 4,403,000USD |
| Other Non Cash Items | 25,021,000USD | -22,375,000USD | 83,379,000USD | 66,025,000USD | 23,649,000USD | 12,369,625USD | -2,912,000USD | -4,643,000USD |
| Change To Account Receivables | -2,262,000USD | -2,392,000USD | -6,138,000USD | -6,138,000USD | 5,775,000USD | -6,641,000USD | -8,860,000USD | -7,312,000USD |
| Change To Inventory | 7,688,000USD | 862,000USD | -2,180,000USD | -5,960,000USD | -2,819,000USD | -12,179,000USD | -10,929,000USD | -6,529,000USD |
| Change In Working Capital | -4,695,000USD | -3,699,000USD | -3,101,000USD | -6,601,000USD | 9,763,000USD | -27,662,000USD | -1,179,000USD | -10,095,000USD |
| Total Cash From Operating Activities | -206,000USD | 257,000USD | -22,593,000USD | -24,399,000USD | 16,471,000USD | -17,041,000USD | 16,020,000USD | 19,779,000USD |
| Capital Expenditures | -13,415,000USD | -18,395,000USD | -29,940,000USD | -28,134,000USD | -25,223,000USD | -26,686,000USD | -44,734,000USD | -33,590,000USD |
| Free Cash Flow | -13,621,000USD | -18,138,000USD | -52,533,000USD | -52,533,000USD | -8,752,000USD | -43,727,000USD | -28,714,000USD | -13,811,000USD |
| Investments | -6,415,000USD | -17,921,000USD | -4,153,000USD | 45,100,000USD | 45,100,000USD | 45,100,000USD | 7,000,000USD | — |
| Total Cashflows From Investing Activities | -6,415,000USD | -18,395,000USD | 79,962,000USD | 81,768,000USD | -12,310,000USD | -23,888,000USD | -96,797,000USD | -35,589,000USD |
| Net Borrowings | -15,721,000USD | 2,168,000USD | 19,398,000USD | -55,411,000USD | 7,470,000USD | 41,775,000USD | 79,908,000USD | — |
| Total Cash From Financing Activities | 6,424,000USD | 7,509,000USD | -57,021,000USD | -57,021,000USD | -3,419,000USD | 40,017,000USD | 79,026,000USD | 13,292,000USD |
| Issuance Of Capital Stock | 23,850,000USD | 0USD | 42,904,000USD | 0USD | 0USD | 30,000USD | 327,000USD | — |
| Change In Cash | -197,000USD | -10,629,000USD | 348,000USD | 348,000USD | 742,000USD | -912,000USD | -1,751,000USD | -2,518,000USD |
| Begin Period Cash Flow | 8,462,000USD | 19,091,000USD | 1,295,000USD | 1,295,000USD | 553,000USD | 1,465,000USD | 3,216,000USD | 5,409,000USD |
| End Period Cash Flow | 8,265,000USD | 8,462,000USD | 1,643,000USD | 1,643,000USD | 1,295,000USD | 553,000USD | 1,465,000USD | 2,891,000USD |
| Other Cashflows From Financing Activities | 1,130,000USD | 5,341,000USD | -1,610,000USD | 73,501,000USD | -10,889,000USD | -1,788,000USD | 23,791,000USD | -5,688,000USD |
| Unclassified Investing Cash Flow | 13,415,000USD | 18,579,000USD | 122,753,000USD | 74,641,000USD | -45,100,000USD | -42,666,000USD | -59,608,000USD | — |
| Unclassified Financing Cash Flow | -2,835,000USD | 3,230,000USD | -73,746,000USD | -75,111,000USD | — | — | -23,273,000USD | 20,458,000USD |
| Dividends Paid | — | -3,078,000USD | -274,000USD | — | — | -212,000USD | -700,000USD | — |
| Sale Purchase Of Stock | — | -152,000USD | -789,000USD | — | -405,000USD | -212,000USD | -700,000USD | -1,478,000USD |
| Other Cashflows From Investing Activities | — | -658,000USD | -8,698,000USD | -9,839,000USD | 12,913,000USD | 364,000USD | 545,000USD | -1,999,000USD |
| Change To Liabilities | — | — | 19,221,000USD | 9,325,000USD | -5,204,000USD | -1,396,000USD | 16,739,000USD | — |
| Unclassified Operating Cash Flow | — | — | -6,825,000USD | -6,884,000USD | -7,874,000USD | -5,440,000USD | — | -7,221,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Product | Contract Development And Manufacturing Organization | 15,552,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | HAManufacturing | 18,615,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Product | Contract Development And Manufacturing Organization | 15,775,000 | USD | 0001005286-26-000020 |
| Q1 2026Quarterly · 2026-03-31 | Product | HAManufacturing | 7,418,000 | USD | 0001005286-26-000020 |
| FY 2025Yearly · 2025-05-31 | Product | Contract Development And Manufacturing Organization | 90,095,000 | USD | 0001005286-25-000108 |
| FY 2025Yearly · 2025-05-31 | Product | HAManufacturing | 38,772,000 | USD | 0001005286-25-000108 |
| Q3 2025Quarterly · 2025-02-28 | Product | Contract Development And Manufacturing Organization | 20,789,000 | USD | 0001005286-26-000020 |
| Q3 2025Quarterly · 2025-02-28 | Product | HAManufacturing | 14,365,000 | USD | 0001005286-26-000020 |
| Q2 2025Quarterly · 2024-11-30 | Product | Contract Development And Manufacturing Organization | 25,610,000 | USD | 0001005286-25-000012 |
| Q2 2025Quarterly · 2024-11-30 | Product | HAManufacturing | 6,954,000 | USD | 0001005286-25-000012 |
| Q1 2025Quarterly · 2024-08-31 | Product | Contract Development And Manufacturing Organization | 20,180,000 | USD | 0001005286-25-000148 |
| Q1 2025Quarterly · 2024-08-31 | Product | HAManufacturing | 4,525,000 | USD | 0001005286-25-000148 |
| Q4 2024Quarterly · 2024-05-31 | Product | Contract Development And Manufacturing Organization | 29,093,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-05-31 | Product | HAManufacturing | 8,792,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-05-31 | Product | Contract Development And Manufacturing Organization | 96,616,000 | USD | 0001005286-24-000124 |
| FY 2024Yearly · 2024-05-31 | Product | HAManufacturing Fermentation | 31,645,000 | USD | 0001005286-24-000124 |
| FY 2024Yearly · 2024-05-31 | Product | Product And Service Other | 0 | USD | 0001005286-24-000124 |
| Q3 2024Quarterly · 2024-02-29 | Product | Contract Development And Manufacturing Organization | 22,306,000 | USD | 0001005286-25-000055 |
| Q3 2024Quarterly · 2024-02-29 | Product | HAManufacturing | 13,398,000 | USD | 0001005286-25-000055 |
| Q2 2024Quarterly · 2023-11-30 | Product | Contract Development And Manufacturing Organization | 23,678,000 | USD | 0001005286-25-000012 |
| Q2 2024Quarterly · 2023-11-30 | Product | HAManufacturing | 6,472,000 | USD | 0001005286-25-000012 |
| FY 2023Yearly · 2023-05-31 | Product | Contract Development And Manufacturing Organization | 76,378,000 | USD | 0001005286-24-000124 |
| FY 2023Yearly · 2023-05-31 | Product | HAManufacturing Fermentation | 26,891,000 | USD | 0001005286-24-000124 |
| FY 2023Yearly · 2023-05-31 | Product | Product And Service Other | 0 | USD | 0001005286-24-000124 |
| Q3 2023Quarterly · 2023-02-28 | Segment | All Other Segments | 0 | USD | 0001005286-23-000095 |
| Q3 2023Quarterly · 2023-02-28 | Segment | Curation Foods | 1,270,000 | USD | 0001005286-23-000095 |
| Q3 2023Quarterly · 2023-02-28 | Segment | Lifecore | 26,330,000 | USD | 0001005286-23-000095 |
| Q2 2023Quarterly · 2022-11-30 | Segment | All Other Segments | 0 | USD | 0001005286-23-000057 |
| Q2 2023Quarterly · 2022-11-30 | Segment | Curation Foods | 17,111,000 | USD | 0001005286-23-000057 |
| Q2 2023Quarterly · 2022-11-30 | Segment | Lifecore | 21,691,000 | USD | 0001005286-23-000057 |
| Q1 2023Quarterly · 2022-08-31 | Segment | All Other Segments | 0 | USD | 0001005286-22-000062 |
| Q1 2023Quarterly · 2022-08-31 | Segment | Curation Foods | 19,652,000 | USD | 0001005286-22-000062 |
| Q1 2023Quarterly · 2022-08-31 | Segment | Lifecore | 23,703,000 | USD | 0001005286-22-000062 |
| FY 2022Yearly · 2022-05-31 | Product | Contract Development And Manufacturing Organization | 86,353,000 | USD | 0001005286-24-000124 |
| FY 2022Yearly · 2022-05-31 | Product | HAManufacturing Fermentation | 23,007,000 | USD | 0001005286-24-000124 |
| FY 2022Yearly · 2022-05-31 | Product | Product And Service Other | 1,910,000 | USD | 0001005286-24-000124 |
| Q4 2022Quarterly · 2022-05-31 | Segment | All Other Segments | 0 | USD | Legacy provider |
| Q4 2022Quarterly · 2022-05-31 | Segment | Curation Foods | 20,014,000 | USD | Legacy provider |
| Q4 2022Quarterly · 2022-05-31 | Segment | Lifecore | 27,614,000 | USD | Legacy provider |
| FY 2022Yearly · 2022-05-31 | Segment | All Other Segments | 0 | USD | 0001005286-22-000047 |
| FY 2022Yearly · 2022-05-31 | Segment | Curation Foods | 76,466,000 | USD | 0001005286-22-000047 |
| FY 2022Yearly · 2022-05-31 | Segment | Lifecore | 109,320,000 | USD | 0001005286-22-000047 |
| Q3 2022Quarterly · 2022-02-28 | Segment | All Other Segments | 0 | USD | 0001005286-23-000095 |
| Q3 2022Quarterly · 2022-02-28 | Segment | Curation Foods | 2,591,000 | USD | 0001005286-23-000095 |
| Q3 2022Quarterly · 2022-02-28 | Segment | Lifecore | 34,808,000 | USD | 0001005286-23-000095 |
| Q2 2022Quarterly · 2021-11-30 | Segment | All Other Segments | 0 | USD | 0001005286-23-000057 |
| Q2 2022Quarterly · 2021-11-30 | Segment | Curation Foods | 18,506,000 | USD | 0001005286-23-000057 |
| Q2 2022Quarterly · 2021-11-30 | Segment | Lifecore | 24,946,000 | USD | 0001005286-23-000057 |
| Q1 2022Quarterly · 2021-08-31 | Segment | All Other Segments | 0 | USD | 0001005286-22-000062 |
| Q1 2022Quarterly · 2021-08-31 | Segment | Curation Foods | 19,680,000 | USD | 0001005286-22-000062 |
| Q1 2022Quarterly · 2021-08-31 | Segment | Lifecore | 21,952,000 | USD | 0001005286-22-000062 |
| Q4 2021Quarterly · 2021-05-31 | Segment | All Other Segments | 0 | USD | Legacy provider |
| Q4 2021Quarterly · 2021-05-31 | Segment | Curation Foods | 207,085,000 | USD | Legacy provider |
| Q4 2021Quarterly · 2021-05-31 | Segment | Lifecore | 25,839,000 | USD | Legacy provider |
| FY 2021Yearly · 2021-05-31 | Segment | All Other Segments | 0 | USD | 0001005286-22-000047 |
| FY 2021Yearly · 2021-05-31 | Segment | Curation Foods | 73,459,000 | USD | 0001005286-22-000047 |
| FY 2021Yearly · 2021-05-31 | Segment | Lifecore | 98,087,000 | USD | 0001005286-22-000047 |
| FY 2020Yearly · 2020-05-31 | Segment | All Other Segments | 0 | USD | 0001005286-22-000047 |
| FY 2020Yearly · 2020-05-31 | Segment | Curation Foods | 74,233,000 | USD | 0001005286-22-000047 |
| FY 2020Yearly · 2020-05-31 | Segment | Lifecore | 85,833,000 | USD | 0001005286-22-000047 |
| FY 2019Yearly · 2019-05-31 | Segment | All Other Segments | 0 | USD | 0001005286-21-000043 |
| FY 2019Yearly · 2019-05-31 | Segment | Curation Foods | 481,686,000 | USD | 0001005286-21-000043 |
| FY 2019Yearly · 2019-05-31 | Segment | Lifecore | 75,873,000 | USD | 0001005286-21-000043 |
| FY 2018Yearly · 2018-05-31 | Segment | All Other Segments | 0 | USD | 0001005286-20-000004 |
| FY 2018Yearly · 2018-05-31 | Segment | Curation Foods | 458,800,000 | USD | 0001005286-20-000004 |
| FY 2018Yearly · 2018-05-31 | Segment | Lifecore | 65,427,000 | USD | 0001005286-20-000004 |
| FY 2017Yearly · 2017-05-31 | Segment | All Other Segments | 0 | USD | 0001628280-19-009791 |
| FY 2017Yearly · 2017-05-31 | Segment | Curation Foods | 410,384,000 | USD | 0001628280-19-009791 |
| FY 2017Yearly · 2017-05-31 | Segment | Lifecore | 59,392,000 | USD | 0001628280-19-009791 |
| FY 2016Yearly · 2016-05-31 | Segment | All Other Segments | 2,589,000 | USD | 0001437749-18-015135 |
| FY 2016Yearly · 2016-05-31 | Segment | Biomaterials | 50,470,000 | USD | 0001437749-18-015135 |
| FY 2016Yearly · 2016-05-31 | Segment | Packaged Fresh Vegetables | 423,859,000 | USD | 0001437749-18-015135 |
| FY 2015Yearly · 2015-05-31 | Segment | Biomaterials | 40,432,000 | USD | 0001437749-17-014444 |
| FY 2015Yearly · 2015-05-31 | Segment | Corporate | 573,000 | USD | 0001437749-17-014444 |
| FY 2015Yearly · 2015-05-31 | Segment | Food Export | 67,837,000 | USD | 0001437749-17-014444 |
| FY 2015Yearly · 2015-05-31 | Segment | Packaged Fresh Vegetables | 430,415,000 | USD | 0001437749-17-014444 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.